Virtu Financial LLC - BROOKLYN IMMUNOTHERAPEUTICS ownership

Back to all holdings Add to watchlist

BROOKLYN IMMUNOTHERAPEUTICS's ticker is BTX and the CUSIP is 114082100. A total of 1 filers reported holding BROOKLYN IMMUNOTHERAPEUTICS in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Virtu Financial LLC ownership history of BROOKLYN IMMUNOTHERAPEUTICS
ValueSharesWeighting
Q3 2022$16,000
-76.5%
63,122
+245.9%
0.00%
-80.0%
Q1 2021$68,000–18,248–0.01%–
 Download
Other shareholders

There were no reported owners of BROOKLYN IMMUNOTHERAPEUTICS in Q4 2022.

NameSharesValueWeighting ↓
View complete list of BROOKLYN IMMUNOTHERAPEUTICS shareholders